Rossmax International Ltd.

TPEX:4121 Stock Report

Market Cap: NT$1.4b

Rossmax International Past Earnings Performance

Past criteria checks 0/6

Rossmax International's earnings have been declining at an average annual rate of -14.3%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 4.4% per year.

Key information

-14.3%

Earnings growth rate

-16.4%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate4.4%
Return on equity-1.8%
Net Margin-0.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Is Rossmax International (GTSM:4121) A Future Multi-bagger?

Mar 02
Is Rossmax International (GTSM:4121) A Future Multi-bagger?

Is There More To The Story Than Rossmax International's (GTSM:4121) Earnings Growth?

Feb 09
Is There More To The Story Than Rossmax International's (GTSM:4121) Earnings Growth?

Is Rossmax International Ltd.'s (GTSM:4121) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jan 05
Is Rossmax International Ltd.'s (GTSM:4121) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Revenue & Expenses Breakdown

How Rossmax International makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4121 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,842-341,32555
30 Jun 243,802-181,27454
31 Mar 243,829-131,25553
31 Dec 233,809-71,21851
30 Sep 233,910351,21550
30 Jun 234,055791,22152
31 Mar 234,3661611,22051
31 Dec 224,3451701,19454
30 Sep 224,3211511,18057
30 Jun 224,1741191,15553
31 Mar 223,9081031,11252
31 Dec 213,9481111,10756
30 Sep 213,9251411,08156
30 Jun 213,9851831,06257
31 Mar 213,8151431,04661
31 Dec 203,6791351,02759
30 Sep 203,45411399764
30 Jun 203,2526197263
31 Mar 203,1813994065
31 Dec 193,0942691964
30 Sep 193,0571291356
30 Jun 193,0641391455
31 Mar 193,0782191848
31 Dec 183,0971791943
30 Sep 183,1842791641
30 Jun 183,2214791540
31 Mar 183,2035790239
31 Dec 173,1532890841
30 Sep 173,0636892841
30 Jun 173,0133593143
31 Mar 173,033-396245
31 Dec 163,1282096946
30 Sep 163,232-5397046
30 Jun 163,322-3699250
31 Mar 163,390-2599850
31 Dec 153,406-281,01852
30 Sep 153,437-51,02455
30 Jun 153,477-181,02956
31 Mar 153,403-141,00557
31 Dec 143,334-395557
30 Sep 143,211-1390255
30 Jun 143,078-1884851
31 Mar 143,025-2582453
31 Dec 132,8541376551

Quality Earnings: 4121 is currently unprofitable.

Growing Profit Margin: 4121 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4121 is unprofitable, and losses have increased over the past 5 years at a rate of 14.3% per year.

Accelerating Growth: Unable to compare 4121's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4121 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).


Return on Equity

High ROE: 4121 has a negative Return on Equity (-1.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 12:25
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rossmax International Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ruijun HuangSinoPac Securities Investment Service